Healthcare -
Biotechnology - NASDAQ - US
$ 46.52
-0.853 %
$ 1.78 B
Market Cap
-12.41
P/E
Price Target
Average
33.28%
Revenue Forecast
Estimate
262.65%
EBIT
Estimate
34.52%
Net Income
Estimate
52.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Tarsus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for TARS of $62 , with forecasts ranging from
a
low of
$61 to a high of $63 .
TARS Lowest Price Target
Wall Street Target
61 USD
31.13%
TARS Average Price Target
Wall Street Target
62 USD
33.28%
TARS Highest Price Target
Wall Street Target
63 USD
35.43%
REVENUE FORECAST
Revenue Forecast Chart TARS
EBIT FORECAST
EBIT Forecast Chart TARS
NET INCOME FORECAST
Net Income Chart TARS